HIV Infections
Showing 1 - 25 of 3,431
Switch From Etravirine to Doravirine asPart of Antiretroviral
Not yet recruiting
- HIV Infections
- (no location specified)
Nov 24, 2023
HIV Trial (Cognitive Behavioral Therapy for Syndemics and Adherence (CBT-SA))
Not yet recruiting
- HIV Infections
- Cognitive Behavioral Therapy for Syndemics and Adherence (CBT-SA)
- (no location specified)
Nov 21, 2023
HIV Trial (behavioral, diagnostic test, other)
Not yet recruiting
- HIV Infections
- General, status-neutral HIV education
- +7 more
- (no location specified)
Nov 22, 2023
HIV Trial in Abidjan (Quantitative research, Qualitative survey)
Recruiting
- HIV Infections
- Quantitative research
- Qualitative survey
-
Abidjan, Côte D'Ivoire
- +1 more
Nov 22, 2023
HIV Trial (CAB LA)
Not yet recruiting
- HIV Infections
- CAB LA
- (no location specified)
Nov 21, 2023
HIV Trial (DRV/r FDC (120/20mg))
Not yet recruiting
- HIV Infections
- DRV/r FDC (120/20mg)
- (no location specified)
Nov 15, 2023
HIV Trial in Johannesburg (Cabotegravir Injection [Apretude], Tenofovir disoproxil fumarate / emtricitabine (or lamivudine))
Not yet recruiting
- HIV Infections
- Cabotegravir Injection [Apretude]
- Tenofovir disoproxil fumarate / emtricitabine (or lamivudine)
-
Johannesburg, Gauteng, South AfricaEzintsha, a division of Wits Health Consortium
Nov 13, 2023
Cellular Kinases and Aging in PBMCs and Colorectal Tissue
Recruiting
- HIV Infections
- Aging
- biopsy
-
Baltimore, MarylandJohns Hopkins University
Nov 6, 2023
Genital Tract Infections, Vaginal Microbiome and Gestational Age
Active, not recruiting
- Sexually Transmitted Infections (Not HIV or Hepatitis)
- +12 more
- No intervention
-
East London, Eastern Cape, South AfricaEmpilweni Gompo Community Health Centre
Nov 8, 2023
HIV, Hiv Trial (Community Antiretroviral Therapy)
Not yet recruiting
- HIV Infections
- Hiv
- Community Antiretroviral Therapy
- (no location specified)
Nov 6, 2023
HIV Trial (Low dose KL-HIV-Tri01, Middle dose KL-HIV-Tri01, High dose KL-HIV-Tri01)
Not yet recruiting
- HIV Infections
- Low dose KL-HIV-Tri01
- +2 more
- (no location specified)
Nov 5, 2023
Virologically Suppressed People Living With HIV and Factors
Completed
- HIV Infections
- dual therapy
-
Tourcoing, FranceCentre Hospitalier DRON
Oct 30, 2023
HIV, Substance Use Disorders Trial in United States (Connections App)
Not yet recruiting
- HIV Infections
- Substance Use Disorders
- Connections App
-
Denver, Colorado
- +7 more
Oct 25, 2023
HIV, Substance Use Disorders, Addiction Trial in Baltimore (Peer-educator-based network)
Not yet recruiting
- HIV Infections
- +5 more
- Peer-educator-based network
-
Baltimore, MarylandJohns Hopkins Hospital
Oct 23, 2023
Gut Microbiome After Changes in Antiretroviral Therapy (ART)
Not yet recruiting
- HIV Infections
- (no location specified)
Oct 20, 2023
HIV Trial (TM HIV, TM HL)
Not yet recruiting
- HIV Infections
- TM HIV
- TM HL
- (no location specified)
Oct 12, 2023
HIV Trial in Houston (Attention-control group, MY-RIDE group)
Not yet recruiting
- HIV Infections
- Attention-control group
- MY-RIDE group
-
Houston, TexasThe University of Texas Health Science Center at Houston
Oct 6, 2023
Support PrEP Medication Persistence
Not yet recruiting
- HIV Infections
- Digital Health Companion (mobile App)
- (no location specified)
Oct 2, 2023
HIV Trial in La Jolla (LOTUS mHealth Intervention Group, LOTUS Control Group)
Not yet recruiting
- HIV Infections
- LOTUS mHealth Intervention Group
- LOTUS Control Group
-
La Jolla, CaliforniaUniversity of California San Diego
Sep 28, 2023
People Living With HIV, Oral and Oropharyngeal Cancer, and
Not yet recruiting
- HIV Infections
- +2 more
- Group Meeting (Focus Group)
- Questionnaires
-
San Francisco, CaliforniaUniversity of California, San Francisco
Sep 20, 2023
HIV, Sexually Transmitted Diseases, Viral, Syphilis Trial in New York, Nashville (mLab App Plus)
Recruiting
- HIV Infections
- +2 more
- mLab App Plus
-
New York, New York
- +1 more
Sep 22, 2023
Severe Mpox in Persons With Advanced HIV
Recruiting
- Monkeypox
- +2 more
-
Atlanta, GeorgiaCenters for Disease Control and Prevention
Sep 18, 2023
HIV Trial in Austin (Cabotegravir Formulation F, Cabotegravir Formulation G)
Not yet recruiting
- HIV Infections
- Cabotegravir Formulation F
- Cabotegravir Formulation G
-
Austin, TexasGSK Investigational Site
Sep 4, 2023